47 studies on P21 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab indexes 21 published P21 COA source records from third-party laboratories, covering 11 publicly attributable vendor identities. Across 18 records with positive numeric purity, the arithmetic mean is 99.12%. 0 records report zero purity; these remain in the record count and are excluded from the positive-purity mean. 0 positive purity results are below 90%; 0 records report measured amount more than 10% below the label. The latest recorded test date is 2026-10-08. TitrateLab did not perform these laboratory tests. Source records are not unique batches, and vendor identity does not establish manufacturing role, product safety or overall quality.
As of 2026-10-18, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 5 mg | $37.50 | $37.50–$37.50 | $7.50 | 1 source · 1 offer |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. View full price methodology →
All published source records, including absent and zero purity. Matching uses a case-insensitive exact peptide token. No deduplication in the headline; vendor rankings deduplicate eligible certificates separately. The COA archive can use normalized compound names and a different measurement or duplicate policy; totals from these populations need not match.
Latest recorded test: 2026-10-08. Aggregate calculated: 2026-10-18T04:26:33.898871+00:00. Calculation time is not a laboratory observation date.
Within that total, 4 source records have unresolved vendor identity. They remain in corpus-level lab evidence and are excluded from named-vendor rankings.
Eligible vendors have at least 2 deduplicated certificates and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and certificate count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes submitted-sample evidence, not every product or shipment, and is not an endorsement.
| Rank | Vendor | Deduplicated certificates | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 5 | 98.87% | 0 of 3 (0.0%) 0 0% / not detected · 0 wrong compound · 2 unclassified | Reveal with Pro → | |
| #2 | 2 | 99.22% | 0 of 2 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #3 | 2 | 99.12% | 0 of 2 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → |
Vendor identities are included with Pro. Record counts and lab measurements remain visible.
Recent source records: #118540 (99.33%) · #116220 (99.26%) · #115971 (99.26%) · #114470 (99.15%) · #107804 (99.19%) · #103160 (99.08%)
The discovery of **78b** and **78d** represents a significant step forward in targeting **KRAS-driven colorectal cancer**, offering potent pan-KRAS therapeutic candidates. These compounds address a critical unmet need…
This research significantly advances our understanding of AMBRA1's critical role in maintaining genomic stability by regulating CKI degradation, particularly `p21Waf1/Cip1`, during the S phase. **The findings suggest …
This study provides crucial insights into the molecular landscape of **wild-type (WT) KRAS colorectal cancer (CRC)**, a subtype often lacking targeted therapies. **Identifying cytoplasmic p27 localization as a feature…
This research fundamentally redefines our understanding of **KRAS** regulation, identifying **Mg2+-sensitive hotspots** that can be exploited for novel therapeutic strategies. By elucidating how **Mg2+** controls **KR…
This study establishes a molecular basis for classifying **TP53** variants of uncertain clinical significance, particularly the **R267W** mutation, as pathogenic. For clinicians and genetic counselors, this provides c…
This study fundamentally shifts our understanding of **p53**'s toxic effects, identifying specific cell cycle regulators (`p21`, `Gtse1`) as key mediators of its detrimental impact, rather than solely apoptosis-relate…
This research provides crucial mechanistic insights into nanoplastic toxicity, highlighting their capacity to induce inflammation and accelerate aging, even in young organisms, through the oral-gut microbiome axis. **…
This study identifies **p16INK4a** as a crucial mechanistic regulator of fibrosis progression, offering a novel therapeutic target for **Idiopathic Pulmonary Fibrosis (IPF)**. For peptide users and biohackers interest…
This research reveals a critical **KRAS**-induced `IFN` program that sensitizes **PDAC** cells to necroptosis, identifying a novel therapeutic vulnerability. For clinicians and researchers, this highlights a potential…
This research uncovers a novel epitranscriptomic mechanism governing **hPDLSC** senescence and chondrogenic differentiation, offering a new therapeutic target for **TMJOA**. **Targeting the YTHDC1-GADD45B-p53/p21 axis…
This study identifies tubular AMD1 as a critical metabolic checkpoint that maintains polyamine homeostasis, preventing `p53/p21`-dependent senescence and promoting adaptive repair after AKI. **Spermidine supplementati…
This research provides a critical mechanistic understanding of how **TiO2 nanoparticles** impair bone growth, specifically targeting chondrocyte function. For those concerned with environmental toxins and developmenta…
High 6PPD exposure is linked to unexplained miscarriage and placental senescence in humans and mice, via `BAZ1B`-mediated `P21` dysregulation.
This study significantly advances the understanding of **RASopathy** genetics in the Indian population, providing a crucial molecular and clinical profile. **Improved diagnostic yield via targeted gene panels** means …
**Genistein shows promise as an effective prophylactic agent against cutaneous radiation injuries and combined injuries.** This finding is highly relevant for developing pre-exposure countermeasures in high-risk scena…
This research identifies **GSTZ1** as a novel and promising complementary target to enhance the efficacy of **KRASG12C inhibitors** in **NSCLC**. For clinicians and biohackers, this suggests that combining **KRASG12C …
This study identifies `GDF15` as a critical mediator of epithelial cell senescence in **radiation-induced lung injury (RILI)**, operating through the `ERK1/2-p16` signaling pathway. **Targeting GDF15 or the ERK1/2-p16…
The discovery of **Peptide-1** offers a promising new avenue for targeting **KRASG12V**, a notoriously difficult-to-drug mutation in **colorectal cancer**. This peptide's selectivity for `KRASG12V` over other KRAS mut…
A novel therapeutic axis, `HDAC-p21-senescence`, is defined, offering a promising strategy to overcome acquired chemoresistance in **bladder cancer**. For clinicians and researchers, this suggests that combining epige…
**AL-VI10 offers a promising new strategy for combating vascular aging by targeting the `CD44-SIRT1-Nrf2` axis**, potentially leading to improved cardiovascular health. This discovery highlights a novel mechanism for …
This research identifies a novel, targetable mechanism for **rheumatoid arthritis** (RA) progression, shifting focus from traditional inflammatory pathways to metabolic reprogramming and protein modification. **Target…
**This study identifies a novel, selective therapeutic strategy for `ARID1A`-mutated cancers, a patient population currently lacking effective targeted treatments.** `WRN` inhibition offers a precise approach by explo…
This research offers a compelling new strategy for tackling **pancreatic ductal adenocarcinoma**, particularly for patients with `KRAS`-mutated tumors, by addressing the critical issue of therapeutic resistance. **Com…
This research identifies a novel mechanism where `SYVN1`-mediated `RASA1` degradation contributes to **COPD** inflammation, suggesting a potential new therapeutic target. **Modulating SYVN1 activity or stabilizing RAS…
Considering immunological age and pre-ART immune senescent status could personalize antiretroviral therapy strategies for **people living with HIV**. This study highlights that a patient's immune profile before starti…
This novel PNA-based method offers a significant leap in **accessible and precise genetic diagnostics**. By eliminating the need for complex thermal cycling equipment, it paves the way for **point-of-care SNP detectio…
This research provides crucial insights into how **early life stress fundamentally reshapes neuroimmune development**, particularly within the hypothalamus. For those interested in mental health and neurodevelopment, …
This study highlights **β-Ecdysterone as a potential therapeutic agent** for mitigating vascular aging and related cardiovascular diseases. For biohackers and individuals interested in longevity, β-Ecd's ability to co…
This research provides a compelling hypothesis for why **KRas-mutated tumors** often resist immunotherapy, suggesting that **cathepsin B** activity in inflammatory microenvironments actively destroys critical neoepito…
The TN-derived P2-1 peptide specifically inhibits the HMGB1-pCTS-L inflammatory axis, preventing RAGE engagement and macrophage pyroptosis to ameliorate sepsis and RA.
Electroacupuncture at ST36 normalized blood glucose and improved glucose tolerance in acute hyperglycemia and prediabetes mice, enhancing pancreatic β-cell function.
This study highlights **electroacupuncture as a promising non-pharmacological intervention for Alzheimer's disease**, demonstrating its potential to improve cognitive function and restore hippocampal myelin integrity.…
Understanding AUF1's role in auditory hair cell senescence and inflammation opens new avenues for therapeutic intervention in **age-related hearing loss**. **Targeting AUF1 could offer a novel strategy for mitigating …
This research provides compelling preclinical evidence that **localized, high-dose magnesium injections could offer a novel, safe therapeutic strategy for cervical cancer**. By inducing a senescence-like state via the…
This research highlights a critical link between alcohol consumption and chemotherapy resistance in **colorectal cancer**, suggesting that **avoiding alcohol during oxaliplatin treatment could improve patient outcomes…
**Understanding the specific naïve CD4 T cell profiles in different HIV contexts could inform novel strategies to target viral reservoirs and prevent immune senescence.** This research suggests that the timing of ART …
Understanding the subcellular compartmentalization of **p21** offers a crucial new lens for developing targeted **cancer** therapies. Instead of broadly modulating p21 expression, future strategies could focus on mani…
This research significantly expands our understanding of neurofibromin's role beyond its well-established RAS-GAP activity, revealing novel **RAS-independent functions** mediated by its cooperation with SPRED1/2. For …
Liraglutide significantly upregulated GLP1R expression and activated cAMP/PKA signaling, inducing apoptosis and cell cycle arrest in MCF7 breast and PC-3 prostate cancer cells.
Accurate and transparent reporting of methodology, especially in data visualization, is absolutely critical for scientific reproducibility and interpretation. This correction ensures that future researchers interpreti…
This research highlights `Meox1` as a novel and potentially critical driver of **hepatocellular carcinoma** progression, offering a new avenue for therapeutic intervention. **Targeting `Meox1` could represent a promis…
This research is critical for understanding the molecular mechanisms behind skin aging and its response to environmental stressors like UVB. If Insulin-Like Growth Factor 1 proves effective in modulating gene expressi…
This study represents a crucial step towards developing more effective and potentially less toxic treatments for pediatric CNS malignancies. The SGT-53 gene therapy, which targets the p53 tumor suppressor gene (a crit…
This study is crucial for understanding the pleiotropic effects of metformin beyond its well-known glucose-lowering capabilities, specifically its potential role in modulating molecular aging processes in prediabetes.…
P21 is a synthetic peptide, precisely defined by its PubChem CID **56599151**, molecular formula **C27H42N6O8**, and a molecular weight of **578.7 g/mol**.
These findings establish `GHRH-R` as a significant molecular target and a prognostic biomarker in **human gastric cancer**. For clinicians and researchers, this opens a new therapeutic window, suggesting that GHRH-R a…
This research significantly advances our understanding of the molecular basis of umami taste, particularly through the novel mechanism of peptide mineral chelates. The identification of specific potent umami peptides …
Free, no account — handy when you're working with P21.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$14 monthly or $88/year
Create an account